Digestive manifestations in patients with COVID-19
DOI:
https://doi.org/10.5281/zenodo.11493394Keywords:
covid-19, ; hemorrhagic shock, gastrointestinal diseases, sars-cov-2Abstract
Introduction: COVID-19 is a disease with a wide clinical spectrum, where digestive manifestations can not only accompany, but sometimes precede respiratory symptoms.
Objective: to describe the main digestive manifestations in patients with COVID-19.
Methods: a bibliographic review was carried out on the subject, where 31 articles in English and Spanish were consulted, available in the PubMed, Medline, Lilacs, SciELO databases and in the Google Scholar search engine.
Development: despite the fact that most patients with COVID-19 present predominantly respiratory symptoms, some may present digestive manifestations, which is determined by the affinity of SARS-CoV-2 for the angiotensin-converting enzyme 2 (ACE-2) receptor, present on the cell surface of much of the digestive tract and to a lesser extent at the liver level.
Conclusions: digestive manifestations in patients with COVID-19 are relatively common and could be a clinical presentation of the disease. Gastrointestinal symptoms reported have been diarrhea, nausea, vomiting, anorexia, abdominal pain and in some cases digestive bleeding. The hepatogram revealed a mild, transient elevation of transaminases without clinical relevance. In severe cases, hypoalbuminemia has been described, without any other element of liver failure.
Downloads
References
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 2020 [citado 24 Oct 2021];579:270-73. Disponible en: https://www.nature.com/articles/s41586-020-2012-7.pdf
Sharma A, Ahmad-Farouk I, kumar-Lal S. COVID-19: A review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses [Internet]. 2021 [citado 24 Oct 2021];13(202):[aprox. 25p.]. Disponible en: https://www.mdpi.com/1999-4915/13/2/202/pdf
World Health Organization. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 march 2020 [Internet]. 2020 [citado 24 Oct 2021]. [aprox. 3 p.]. Disponible en: https://www.who.int/es/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 [citado 25 oct 2021];395(10223):497-506. Disponible en: https://doi.org/10.1016/S0140-6736(20)30183-5
Synowiec A, Szczepanski A, Barreto-Duran E, Lie LK, Pyrc K. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): a systemic infection. Clin Microbiol Rev [Internet]. 2021 [citado 25 Oct 2021];34(2):e00133-20. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849242/pdf/CMR.00133-20.pdf
Rahman S, Villagomez-Montero MT, Rowe K, Kirton R, Kunik F. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol [Internet]. 2021 [citado 25 Oct 2021];14(5):[aprox. 21 p]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095162/pdf/IERJ_0_1902303.pdf
Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Shekher-Aggarwal C, Golamari R, et al. Gastrointestinal manifestations of COVID-19: A review of what we know. Ochsner J [Internet]. 2021 [citado 27 Oct 2021];21:177–80. Disponible en: http://www.ochsnerjournal.org/content/ochjnl/21/2/177.full.pdf
Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int [Internet]. 2020 [citado 27 Oct 2021];40(9):2095–2103. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.14455
Su S, Shen J, Zhu L, Qiu Y, He JS, Tan JY, et al. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Ther Adv Gastroenterol [Internet]. 2020 [citado 27 Oct 2021];13:1–12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303511/pdf/10.1177_1756284820934626.pdf
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA [Internet]. 2020 [citado 27 Oct 2021];323(13):1239-42. Disponible en: https://jamanetwork.com/journals/jama/articlepdf/2762130/jama_wu_2020_vp_200028.pdf
Díaz P LA, Espino EA. Manifestaciones gastrointestinales de pacientes infectados con el nuevo coronavirus SARS-CoV-2. Gastroenterol Latinoam [Internet]. 2020 [citado 27 Oct 2021]; 31(1):35–8. Disponible en: https://gastrolat.org/DOI/PDF/10.46613/gastrolat202001-05.pdf
Infante-Velázquez M. Implicaciones de la infección por el nuevo coronavirus SARS-Cov-2 para
el sistema digestivo. Arch Cub Gastroenterol [Internet]. 2020 [citado 28 Oct 2021];1(2):e38. Disponible en: https://revgastro.sld.cu/index.php/gast/article/download/38/119
Meng XJ, Liang TJ. SARS-CoV-2 infection in the gastrointestinal tract: fecal–oral route of transmission for COVID-19? Gastroenterol [Internet]. 2021 [citado 28 Oct 2021];160(5):1467–74. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790455/pdf/main.pdf
Chen ZR, Liu J, Liao ZG, Zhou J, Peng HW, Gong F, et al. COVID-19 and gastroenteric manifestations. World J Clin Cases [Internet]. 2021 [citado 28 Oct 2021];9(19):4990–97. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283602/pdf/WJCC-9-4990.pdf
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med [Internet]. 2020 [citado 28 Oct 2021];382:929–36. Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa2001191
Sanz-Segura P, Arguedas-Lázaro Y, Mostacero-Tapia S, Cabrera-Chaves T, Sebastián-Domingo JJ. Afectación del aparato digestivo en la covid-19. Una revisión sobre el tema. Gastroenterol Hepatol [Internet]. 2020 [citado 29 Oct 2021];43(8):464–71. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303613/pdf/main.pdf
Wong SH, Lui RNS, Sung JJY. Covid-19 and the digestive system. J Gastroenterol Hepatol [Internet]. 2020 [citado 29 Oct 2021];35:744–48. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15047
Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg [Internet]. 2021 [citado 29 Oct 2021]: [aprox. 27 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989191/pdf/trab042.pdf
Freire-Alberca GG, Solis-Castro RL, Solis-Castro ME, Alberca RW. Coronavirus disease–2019 and the intestinal tract: An overview. World J Gastroenterol [Internet]. 2021[citado 29 Oct 2021];27(13):1255-66. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015300/pdf/WJG-27-1255.pdf
Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Raymond Liu, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong Cohort: systematic review and meta-analysis. Gastroenterol [Internet]. 2020 [citado 28 Oct 2021];159:81–95. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015300/pdf/WJG-27-1255.pdf
Ghoshal UC, Ghoshal U, Mathur A, Singh RK, Nath A, Garg A, et al. The spectrum of gastrointestinal symptoms in patients with coronavirus disease-19: Predictors, relationship with disease severity, and outcome. Clin Transl Gastroenterol [Internet]. 2020 [citado 29 Oct 2021];11:[aprox. 9p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678797/pdf/ct9-11-e00259.pdf
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol [Internet]. 2020 [citado 30 Oct 2021];115(5):766–73. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172492/pdf/acg-publish_ahead_of_print-10.14309_ajg.0000000000000620.pdf
Chen H, Tong Z, Ma Z, Luo L, Tang Y, Teng Y, et al. Gastrointestinal bleeding, but not other gastrointestinal symptoms, is associated with worse outcomes in COVID-19 patients. Front Med [Internet]. 2021 [citado 30 Oct 2021];8:[aprox. 8p.] Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548414/pdf/fmed-08-759152.pdf
Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int [Internet]. 2020 [citado 30 Oct 2021];40:998–1004. Disponible en: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.14435
Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol [Internet]. 2021 [citado 30 Oct 2021];27(26):3951–70. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311530/pdf/WJG-27-3951.pdf
Téllez L, Martín Mateos RM. Actualización en COVID-19 y enfermedad hepática. Gastroenterol Hepatol [Internet]. 2020 [citado 1 Nov 2021];43(8):472–80. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332955/pdf/main.pdf
Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V. COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? Arch Toxicol [Internet]. 2020 [citado 1 Nov 2021];94(1):1367–9. Disponible en: https://cris.vub.be/ws/files/79941664/51694828.pdf
Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, et al. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol [Internet]. 2020 [citado 1 Nov 2021];26(48):7693–7706. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789052/pdf/WJG-26-7693.pdf
Dawood RM, Salum GM, El-Meguid MA. The impact of COVID-19 on liver injury. Am J Med Sci [Internet]. 2021 [citado 1 Nov 2021]:363(2):94-103. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571104/pdf/main.pdf
Bangash MN, Patel J, Parekh D. COVID-19 and the liver: Little cause for concern. Lancet Gastroenterol Hepatol [Internet]. 2020 [citado 2 Nov 2021];5(6):529-30. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270582/pdf/main.pdf
Fan Z, Chen L, Li J, Yang J, Tian C, Zhang Y, et al. Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol [Internet].2020 [citado 1 Nov 2021];18(7):1561–6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194865/pdf/main.pdf
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Alberto Martínez Sarmiento
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
